Medication adherence in Greek hemodialysis patients: The contribution of depression and health cognitions

International Journal of Behavioral Medicine

Volumn 20, Issue 2, 2013, Pages 311-318

  Theofilou, Paraskevi ^a  

^a PANTEION UNIVERSITY   (Greece)

Author keywords

Adherence; Depression; Health cognitions; Hemodialysis; Medication

Indexed keywords

ADULT; ATTITUDE TO HEALTH; COGNITION; CONTROL; DEPRESSION; FEMALE; GREECE; HUMAN; MALE; MEDICATION COMPLIANCE; MENTAL HEALTH; MIDDLE AGED; NONPARAMETRIC TEST; PSYCHOLOGY; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; ARTICLE; CHRONIC KIDNEY FAILURE; PSYCHOLOGICAL ASPECT;

ADULT; ATTITUDE TO HEALTH; COGNITION; DEPRESSION; FEMALE; GREECE; HUMANS; INTERNAL-EXTERNAL CONTROL; MALE; MEDICATION ADHERENCE; MENTAL HEALTH; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; STATISTICS, NONPARAMETRIC;

EID: 84877927042     PISSN: 10705503     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12529-012-9231-8     Document Type: Article

References (45)

1. Ginieri-Coccossis M, Theofilou P, Synodinou C, Tomaras V, Soldatos C. Quality of life, mental health and health beliefs in haemodialysis and peritoneal dialysis patients: investigating differences in early and later years of current treatment. BMC Nephrol. 2008;9:1-9.
2. Theofilou P. Sexual functioning in chronic kidney disease: the association with depression and anxiety. Hemodial Int. 2011. doi: 10.1111/j.1542-4758.2011.00585.x.
3. Theofilou P. Depression and anxiety in patients with chronic renal failure: the effect of sociodemographic characteristics. Int. J. Nephrol. 2011; 1-6.
4. Theofilou P. Quality of life in patients undergoing haemodialysis or peritoneal dialysis treatment. J Clin Med Res. 2011;3:132-8.
5. Theofilou P. The relation of social support to mental health and locus of control. J Renal Nurs. 2012;4:18-22.
6. Theofilou P. Self-esteem in Greek dialysis patients: the contribution of health locus of control. Iran J Kidney Dis. 2012;6:2.
7. Manley HJ, Garvin CG, Drayer DK, Reid GM, Bender WL, Neufeld TK. Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transplant. 2004;19:1842-8.
8. Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adize T, Mehrotra R. Pill burden, adherence, hyperphosphatemia and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009;4:1089-109.
9. Theofilou P. Non-compliance with medical regimen in haemodialysis treatment: a case study. Case Reports in Nephrology 2011; 1-4.
10. Sabate E. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization; 2003.
11. Haynes R, Ackloo E, Sahota N, McDonald H. Interventions for enhancing medication adherence. Cochrane Database Syst Rev (2) 2008; CD000011.
12. National Kidney Foundation. Clinical practice guidelines and clinical practice recommendations for hemodialysis adequacy, update 2006. Am J Kidney Dis. 2006;48:S2-S90.
13. Timmers L, Thong SYM, Dekker WF. Illness perceptions in dialysis patients and their association with quality of life. Psychol Heal. 2008;23:679-90.
14. Theofilou P. Quality of life and mental health in haemodialysis and peritoneal dialysis patients: the role of health beliefs. Int Urol Nephrol. 2011e. doi: 10.1007/s11255-011-9975-0.
15. Cameron C. Patient compliance: recognition of factors involved and suggestions for promoting compliance with therapeutic regimens. J Adv Nurs. 1996;24:244-50.
16. Marks I. Deconstructing locus of control: implications for practitioners. J Couns Dev. 1998;76:251.
17. Kehoe WA, Katz RC. Health behavior and pharmacotherapy. Ann Pharmachother. 1998;32:1076-86.
18. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Heal. 2002;17:17-32.
19. Axelsson M. Personality and adherence to medication treatment. Sweden: Intellecta Infolog AB; 2011.
20. Mårdby AC, Åkerlind I, Jörgensen T. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Counsel. 2007;69:158-64.
21. Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res. 1999;46:437-43.
22. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
23. Zich JM, Attkisson CC. Screening for depression in primary care clinics: the CES-D and the BDI. Int J Psychiatry Med. 1990;20:259-77.
24. Geisser ME, Roth RS, Robinson ME. Assessing depression among persons with chronic pain using the Center for Epidemiological Studies Depression Scale and the Beck Depression Inventory: a comparative analysis. Clin J Pain. 1997;13:163-70.
25. Wallston BS, Wallston KA. The development and validation of the health related locus of control (HLC) scale. J Consult Clin Psychol. 1976;44:580-5.
26. Wallston BS, Wallston KA, DeVellis R. Development of the multidimensional health locus of control (MHLC) scale. Heal Educ Monogr. 1978;6:160-70.
27. Hong TB, Oddone EZ, Dudley TK, Bosworth HB. Medication barriers and anti-hypertensive medication adherence: the moderating role of locus of control. Psychol Health Med. 2006;11:20-8.
28. Myers L, Myers F. The relationship between control beliefs and self-reported adherence in adults with cystic fibrosis. Psychol Health Med. 1999;4:387-91.
29. Christiansen A, Wiebe J, Benotsch E, Lawton W. Perceived health competence, health locus of control, and patient adherence in renal dialysis. Cogn Ther Res. 1996;20:411-21.
30. Azlin B, Hatta S, Norzila Z, Sharifa Ezat WP. Health locus of control among non-compliance hypertensive patients undergoing pharmacotherapy. Malays J Psychiatry. 2007;16:20-39.
31. Karamanidou C, Clatworthy J, Weinman J, Horne R. A systematic review of the prevalence and determinants of non-adherence to phosphate binding medication in patients with end stage renal disease. BMC Nephrol. 2008;9:1-10.
32. Akman B, Uyar M, Afsar B. Adherence, depression and quality of life in patients on a renal transplantation waiting list. Transpl Int. 2007;5:1-6.
33. Harris T, Cook D, Victor C, Rink E, Mann A, Shah S, et al. Predictors of depressive symptoms in older people - a survey of two general practice populations. Age and Ageing. 2003;32:510-8.
34. Meyers KR. Religiosity and health locus of control as predictors of depression and anxiety in women with breast cancer. ETD Collection for Fordham University. 2002; Paper AAI3056149 http://fordham.bepress.com/dissertations/ AAI3056149
35. Granger BB, Ekman I, Granger CB, Ostergren J, Olofsson B, Michelson E, et al. Adherence to medication according to sex and age in the CHARM programme. Eur J Hear Fail. 2009;11:1092-8.
36. Moreira L, Fernandes P, Monte S, Martins A. Adesão ao tratamento farmacológico em pacientes com doença renal crônica. J Bras Nefrol. 2008;30:113-9.
37. Adisa R, Fakeye TO, Fasanmade A. Medication adherence among ambulatory patients with type 2 diabetes in a tertiary healthcare setting in southwestern Nigeria. Pharmacy Practice (Internet). 2011;9:72-81.
38. Ponnusankar S, Surulivelrajan M, Anandamoorthy N. Assessment of impact of medication counseling on patients' medication knowledge and compliance in an outpatient clinic in South India. Patient Educ Couns. 2004;54:55-60.
39. Choi-Kwon S, Kwon SU, Kim JS. Compliance with risk factor modification: early-onset versus late-onset stroke patients. Eur Neurol. 2005;54:204-11.
40. Mishra P, Hansen EH, Sabroe S. Socio-economic status and adherence to tuberculosis treatment: a case-control study in a district of Nepal. Int J Tuberc Lung Dis. 2005;9:1134-9.
41. Theofilou P, Geitona M. Comparative study of bicarbonate dialysis and haemodiafiltration in end-stage renal disease. Farmacoeconomics. 2008;36:5-11.
42. Gascon JJ, Sanchez-Ortuno M, Llor B. Treatment compliance in hypertension study group. Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract. 2004;21:125-30.
43. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant. 1994;8:550-7.
44. Combs DL, O'Brien RJ, Geiter LJ. Compliance with tuberculosis regimes: results from USPHS therapy trial 21. Am Rev Respir Dis. 1987;135:138.
45. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ. 1982;60:556-64.